Yadav, H., Lee, J.-H., Lloyd, J., Walter, P., & Rane, S
Key Health Benefits Beyond Diabetes and Weight Loss a) Cardiovascular Health Clinical trials show GLP-1 drugs lower risks of heart attacks, strokes, and cardiac deaths by improving cholesterol and reducing artery inflammation
GLP-1 agonists overall were associated with a 3.67 times higher risk of developing gastroparesis compared to non-users, but within that elevated risk category, tirzepatide appears significantly safer than semaglutide
Patients are left to navigate a fragmented maze
Always discuss treatment options with your GP to determine suitability based on your individual circumstances